業績

業績（2022年～）

英文原著・総説

Relationship of emergency department visits for suicide attempts with meteorological and air pollution conditions. Miyazaki H, Hino K, Ito T, Abe T, Nomoto M, Furuno T, Takeuchi I, Hishimoto A. J Affect Disord. 2023 Apr 18:S0165-0327(23)00518-9. doi: 10.1016/j.jad.2023.04.057. Online ahead of print. PMID: 37080497

Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. Eiro T, Miyazaki T, Hatano M, Nakajima W, Arisawa T, Takada Y, Kimura K, Sano A, Nakano K, Mihara T, Takayama Y, Ikegaya N, Iwasaki M, Hishimoto A, Noda Y, Miyazaki T, Uchida H, Tani H, Nagai N, Koizumi T, Nakajima S, Mimura M, Matsuda N, Kanai K, Takahashi K, Ito H, Hirano Y, Kimura Y, Matsumoto R, Ikeda A, Takahashi T. Cell Rep Med. 2023 Apr 11:101020. doi: 10.1016/j.xcrm.2023.101020. Online ahead of print. PMID: 37080205

Telencephalon Organoids Derived from an Individual with ADHD Show Altered Neurodevelopment of Early Cortical Layer Structure. Zhang D, Eguchi N, Okazaki S, Sora I, Hishimoto A. Stem Cell Rev Rep. 2023 Mar 6. doi: 10.1007/s12015-023-10519-z. Online ahead of print. PMID: 36872412

Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia. Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Noguchi N, Furuno T, Asami T, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Saeki T, Fukushima T, Moritani T, Saigusa Y, Hishimoto A. BMC Psychiatry. 2023 Mar 3;23(1):135. doi: 10.1186/s12888-023-04617-y. PMID: 36869320

Epigenetic clock analysis reveals increased plasma cystatin C levels based on DNA methylation in major depressive disorder. Tanifuji T, Okazaki S, Otsuka I, Mouri K, Horai T, Shindo R, Shirai T, Hishimoto A. Psychiatry Res. 2023 Apr;322:115103. doi: 10.1016/j.psychres.2023.115103. Epub 2023 Feb 8. PMID: 36803907

Ribosomal DNA gene copies are increased in blood and brain of Japanese schizophrenia patients. Li S, Otsuka I, Tanifuji T, Okazaki S, Horai T, Takahashi M, Kondo T, Ueno Y, Hishimoto A. PLoS One. 2023 Jan 20;18(1):e0280694. doi: 10.1371/journal.pone.0280694. eCollection 2023. PMID: 36662828

The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project. Kyou Y, Yasui-Furukori N, Hasegawa N, Ide K, Ichihashi K, Hashimoto N, Hori H, Shimizu Y, Imamura Y, Muraoka H, Iida H, Ohi K, Yasuda Y, Ogasawara K, Numata S, Iga JI, Tsuboi T, Ochi S, Kodaka F, Furihata R, Onitsuka T, Makinodan M, Komatsu H, Takeshima M, Kubota C, Hishimoto A, Atake K, Yamagata H, Kido M, Nagasawa T, Usami M, Kishimoto T, Kikuchi S, Matsumoto J, Miura K, Yamada H, Watanabe K, Inada K, Hahimoto R. Ann Gen Psychiatry. 2022 Dec 26;21(1):52. doi: 10.1186/s12991-022-00429-8. PMID: 36567327

Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans. Kimbrel NA, Ashley-Koch AE, Qin XJ, Lindquist JH, Garrett ME, Dennis MF, Hair LP, Huffman JE, Jacobson DA, Madduri RK, Trafton JA, Coon H, Docherty AR, Mullins N, Ruderfer DM, Harvey PD, McMahon BH, Oslin DW, Beckham JC, Hauser ER, Hauser MA; Million Veteran Program Suicide Exemplar Workgroup, the International Suicide Genetics Consortium, the Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center Workgroup, and the Veterans Affairs Million Veteran Program. JAMA Psychiatry. 2023 Feb 1;80(2):135-145. doi: 10.1001/jamapsychiatry.2022.3896. PMID: 36515925

Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project. Iida H, Okada T, Nemoto K, Hasegawa N, Numata S, Ogasawara K, Miura K, Matsumoto J, Hori H, Iga JI, Ichihashi K, Hashimoto N, Yamada H, Ohi K, Yasui-Furukori N, Fukumoto K, Tsuboi T, Usami M, Furihata R, Takaesu Y, Hishimoto A, Muraoka H, Katsumoto E, Nagasawa T, Ochi S, Komatsu H, Kikuchi S, Takeshima M, Onitsuka T, Tamai S, Kubota C, Inada K, Watanabe K, Kawasaki H, Hashimoto R. Neuropsychopharmacol Rep. 2023 Mar;43(1):23-32. doi: 10.1002/npr2.12300. Epub 2022 Nov 28. PMID: 36444167

Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders. Fukumoto K, Kodaka F, Hasegawa N, Muraoka H, Hori H, Ichihashi K, Yasuda Y, Iida H, Ohi K, Ochi S, Ide K, Hashimoto N, Usami M, Nakamura T, Komatsu H, Okada T, Nagasawa T, Furihata R, Atake K, Kido M, Kikuchi S, Yamagata H, Kishimoto T, Makinodan M, Horai T, Takeshima M, Kubota C, Asami T, Katsumoto E, Hishimoto A, Onitsuka T, Matsumoto J, Miura K, Yamada H, Yasui-Furukori N, Watanabe K, Inada K, Otsuka K, Hashimoto R. Neuropsychopharmacol Rep. 2023 Mar;43(1):33-39. doi: 10.1002/npr2.12301. Epub 2022 Nov 16. PMID: 36394160

The psychological distress and suicide-related ideation in hospital workers during the COVID-19 pandemic: Second results from repeated cross-sectional surveys. Ide K, Asami T, Suda A, Yoshimi A, Fujita J, Shiraishi Y, Nomoto M, Miyauchi M, Roppongi T, Furuno T, Watanabe K, Shimada T, Kaneko T, Saigusa Y, Kubota K, Kato H, Odawara T, Hishimoto A. PLoS One. 2022 Nov 10;17(11):e0277174. doi: 10.1371/journal.pone.0277174. eCollection 2022. PMID: 36355760

Obsessive-Compulsive Disorder with Psychotic Features: Is It a Clinical Entity? Okamura Y, Murahashi Y, Umeda Y, Misumi T, Asami T, Itokawa M, Harima H, Mizuno M, Matsunaga H, Hishimoto A. Healthcare (Basel). 2022 Sep 29;10(10):1910. doi: 10.3390/healthcare10101910. PMID: 36292356

Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia". Inada K, Fukumoto K, Hasegawa N, Yasuda Y, Yamada H, Hori H, Ichihashi K, Iida H, Ohi K, Muraoka H, Kodaka F, Ide K, Hashimoto N, Iga JI, Ogasawara K, Atake K, Takaesu Y, Nagasawa T, Komatsu H, Okada T, Furihata R, Kido M, Kikuchi S, Kubota C, Makinodan M, Ochi S, Takeshima M, Yamagata H, Matsumoto J, Miura K, Usami M, Kishimoto T, Onitsuka T, Katsumoto E, Hishimoto A, Numata S, Yasui-Furukori N, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2022 Dec;42(4):502-509. doi: 10.1002/npr2.12293. Epub 2022 Oct 18. PMID: 36254805

Epigenetic clock analysis in methamphetamine dependence. Takemura Y, Tanifuji T, Okazaki S, Shinko Y, Otsuka I, Horai T, Shirai T, Aso K, Yamamoto N, Hishimoto A. Psychiatry Res. 2022 Nov;317:114901. doi: 10.1016/j.psychres.2022.114901. Epub 2022 Oct 12. PMID: 36244160

Preventive effects of preoperative ramelteon on postoperative delirium in Asian elderly population: A randomized, double-blind, placebo-controlled trial, and a systematic review and meta-analysis. Tanifuji T, Otsuka I, Okazaki S, Horai T, So R, Shiroiwa K, Mouri K, Tanaka M, Ohmoto N, Sora I, Hirai M, Fukumoto T, Ku Y, Hishimoto A. Asian J Psychiatr. 2022 Dec;78:103282. doi: 10.1016/j.ajp.2022.103282. Epub 2022 Oct 4. PMID: 36242830

Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis. Tsuboi T, Takaesu Y, Hasegawa N, Ochi S, Fukumoto K, Ohi K, Muraoka H, Okada T, Kodaka F, Igarashi S, Iida H, Kashiwagi H, Hori H, Ichihashi K, Ogasawara K, Hashimoto N, Iga JI, Nakamura T, Usami M, Nagasawa T, Kido M, Komatsu H, Yamagata H, Atake K, Furihata R, Kikuchi S, Horai T, Takeshima M, Hirano Y, Makinodan M, Matsumoto J, Miura K, Hishimoto A, Numata S, Yamada H, Yasui-Furukori N, Inada K, Watanabe K, Hashimoto R. Psychiatry Clin Neurosci. 2023 Jan;77(1):30-37. doi: 10.1111/pcn.13489. Epub 2022 Nov 9. PMID: 36215112

Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia. Okada T, Hori H, Hasegawa N, Murata A, Kyou Y, Kodaka F, Iida H, Ochi S, Takaesu Y, Tsuboi T, Iga JI, Ichihashi K, Muraoka H, Furihata R, Yasui-Furukori N, Usami M, Onitsuka T, Ogasawara K, Tagata H, Takeshima M, Ohi K, Numata S, Hashimoto N, Yamada H, Makinodan M, Komatsu H, Hishimoto A, Yamagata H, Kido M, Kubota C, Atake K, Yamada H, Nagasawa T, Matsumoto J, Miura K, Inada K, Watanabe K, Suda S, Hashimoto R. J Clin Psychopharmacol. 2022 Nov-Dec 01;42(6):591-593. doi: 10.1097/JCP.0000000000001604. Epub 2022 Oct 3. PMID: 36193896

Electroconvulsive therapy for severe depressive symptoms in a patient with dementia with Lewy bodies after coil embolisation for a cerebral aneurysm. Minami K, Asami T, Tsujimura S, Suda A, Ide K, Hishimoto A. Psychogeriatrics. 2022 Nov;22(6):886-889. doi: 10.1111/psyg.12895. Epub 2022 Sep 21. PMID: 36131597

Effectiveness of anger-focused emotional management training in reducing aggression among nurses. Tanabe Y, Asami T, Yoshimi A, Abe K, Saigusa Y, Hayakawa M, Fujita J, Ide K, Suda A, Hishimoto A. Nurs Open. 2023 Feb;10(2):998-1006. doi: 10.1002/nop2.1367. Epub 2022 Sep 16. PMID: 36111753

Successful electroconvulsive therapy for 22q11.2 deletion syndrome with Schizophrenia and Parkinson's disease. Tanifuji T, Otsuka I, Kimura A, Horai T, Okazaki S, Satake W, Hishimoto A. Psychiatry Clin Neurosci. 2022 Nov;76(11):603-604. doi: 10.1111/pcn.13467. Epub 2022 Sep 24. PMID: 36057137

Impact of health literacy on anxiety and depressive symptoms in pregnant women in Japan during the COVID-19 pandemic. Haruyama Y, Miyagi E, Kobashi G, Obata S, Umazume T, Yoshimi A, Hishimoto A, Kurasawa K, Suzuki Y, Ikeda T, Kimura T, Yamada H. Sci Rep. 2022 Aug 18;12(1):14042. doi: 10.1038/s41598-022-18405-3. PMID: 35982222

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study. Hishimoto A, Yasui-Furukori N, Sekine D, Matsukawa M, Yamada S. Adv Ther. 2022 Sep;39(9):4299-4314. doi: 10.1007/s12325-022-02252-9. Epub 2022 Jul 29. PMID: 35904721

Author Correction: Improving polygenic prediction in ancestrally diverse populations. Ruan Y, Lin YF, Feng YA, Chen CY, Lam M, Guo Z; Stanley Global Asia Initiatives; He L, Sawa A, Martin AR, Qin S, Huang H, Ge T. Nat Genet. 2022 Aug;54(8):1259. doi: 10.1038/s41588-022-01144-6. PMID: 35789324

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study. Ochi S, Tagata H, Hasegawa N, Yasui-Furukori N, Iga JI, Kashiwagi H, Kodaka F, Komatsu H, Tsuboi T, Tokutani A, Numata S, Ichihashi K, Onitsuka T, Muraoka H, Iida H, Ohi K, Atake K, Kishimoto T, Hori H, Takaesu Y, Takeshima M, Usami M, Makinodan M, Hashimoto N, Fujimoto M, Furihata R, Nagasawa T, Yamada H, Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno SI, Watanabe K, Inada K, Hashimoto R. Int J Neuropsychopharmacol. 2022 Oct 25;25(10):818-826. doi: 10.1093/ijnp/pyac036. PMID: 35723038

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study. Muraoka H, Kodaka F, Hasegawa N, Yasui-Furukori N, Fukumoto K, Kashiwagi H, Tagata H, Hori H, Atake K, Iida H, Ichihashi K, Furihata R, Tsuboi T, Takeshima M, Komatsu H, Kubota C, Ochi S, Takaesu Y, Usami M, Nagasawa T, Makinodan M, Nakamura T, Kido M, Ueda I, Yamagata H, Onitsuka T, Asami T, Hishimoto A, Ogasawara K, Katsumoto E, Miura K, Matsumoto J, Ohi K, Yamada H, Watanabe K, Inada K, Nishimura K, Hashimoto R. Asian J Psychiatr. 2022 Aug;74:103174. doi: 10.1016/j.ajp.2022.103174. Epub 2022 May 18. PMID: 35661492

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics. Hori H, Yasui-Furukori N, Hasegawa N, Iga JI, Ochi S, Ichihashi K, Furihata R, Kyo Y, Takaesu Y, Tsuboi T, Kodaka F, Onitsuka T, Okada T, Murata A, Kashiwagi H, Iida H, Hashimoto N, Ohi K, Yamada H, Ogasawara K, Yasuda Y, Muraoka H, Usami M, Numata S, Takeshima M, Yamagata H, Nagasawa T, Tagata H, Makinodan M, Kido M, Katsumoto E, Komatsu H, Matsumoto J, Kubota C, Miura K, Hishimoto A, Watanabe K, Inada K, Kawasaki H, Hashimoto R. Front Psychiatry. 2022 May 17;13:823826. doi: 10.3389/fpsyt.2022.823826. eCollection 2022. PMID: 35656353

Improving polygenic prediction in ancestrally diverse populations. Ruan Y, Lin YF, Feng YA, Chen CY, Lam M, Guo Z; Stanley Global Asia Initiatives; He L, Sawa A, Martin AR, Qin S, Huang H, Ge T. Nat Genet. 2022 May;54(5):573-580. doi: 10.1038/s41588-022-01054-7. Epub 2022 May 5. PMID: 35513724

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project. Yamada H, Motoyama M, Hasegawa N, Miura K, Matsumoto J, Ohi K, Yasui-Furukori N, Numata S, Takeshima M, Sugiyama N, Nagasawa T, Kubota C, Atake K, Tsuboi T, Ichihashi K, Hashimoto N, Inagaki T, Takaesu Y, Iga JI, Hori H, Onitsuka T, Komatsu H, Hishimoto A, Fukumoto K, Fujimoto M, Nakamura T, Nemoto K, Furihata R, Yamamura S, Yamagata H, Ogasawara K, Katsumoto E, Murata A, Iida H, Ochi S, Makinodan M, Kido M, Kishimoto T, Yasuda Y, Usami M, Suwa T, Inada K, Watanabe K, Hashimoto R. BJPsych Open. 2022 Apr 21;8(3):e83. doi: 10.1192/bjo.2022.44. PMID: 35446248

Epigenetic aging in Williams syndrome. Okazaki S, Kimura R, Otsuka I, Tomiwa K, Funabiki Y, Hagiwara M, Murai T, Hishimoto A. J Child Psychol Psychiatry. 2022 Dec;63(12):1553-1562. doi: 10.1111/jcpp.13613. Epub 2022 Apr 13. PMID: 35416284

Problematic Internet use and daily difficulties among adolescents with school refusal behaviors: An observational cross-sectional analytical study. Fujita J, Aoyama K, Saigusa Y, Miyazaki H, Aoki Y, Asanuma K, Takahashi Y, Hishimoto A. Medicine (Baltimore). 2022 Feb 18;101(7):e28916. doi: 10.1097/MD.0000000000028916. PMID: 35363214

Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia. Okazaki S, Boku S, Watanabe Y, Otsuka I, Horai T, Morikawa R, Kimura A, Shimmyo N, Tanifuji T, Someya T, Hishimoto A. PLoS One. 2022 Mar 24;17(3):e0265738. doi: 10.1371/journal.pone.0265738. eCollection 2022. PMID: 35324982

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry. Ogasawara K, Numata S, Hasegawa N, Nakataki M, Makinodan M, Ohi K, Takeshima M, Tsuboi T, Hashimoto N, Onitsuka T, Muraoka H, Hori H, Ichihashi K, Inagaki T, Yasui-Furukori N, Hishimoto A, Sugiyama N, Fukumoto K, Nagasawa T, Matsumoto J, Takaesu Y, Furihata R, Nemoto K, Nakamura T, Usami M, Miura K, Fujimoto M, Tagata H, Yamada H, Komatsu H, Ochi S, Atake K, Katsumoto E, Kido M, Kishimoto T, Suwa T, Yamamura S, Iga JI, Iida H, Inada K, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2022 Jun;42(2):221-225. doi: 10.1002/npr2.12245. Epub 2022 Mar 10. PMID: 35272393

Epigenetic clock analysis and increased plasminogen activator inhibitor-1 in high-functioning autism spectrum disorder. Okazaki S, Kimura R, Otsuka I, Funabiki Y, Murai T, Hishimoto A. PLoS One. 2022 Feb 3;17(2):e0263478. doi: 10.1371/journal.pone.0263478. eCollection 2022. PMID: 35113965

Accelerated epigenetic age and shortened telomere length based on DNA methylation in Nicolaides-Baraitser syndrome. Shinko Y, Okazaki S, Otsuka I, Horai T, Kim S, Tanifuji T, Hishimoto A. Mol Genet Genomic Med. 2022 Mar;10(3):e1876. doi: 10.1002/mgg3.1876. Epub 2022 Jan 29. PMID: 35092358

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project. Ichihashi K, Kyou Y, Hasegawa N, Yasui-Furukori N, Shimizu Y, Hori H, Hashimoto N, Ide K, Imamura Y, Yamada H, Ochi S, Iga JI, Takaesu Y, Ohi K, Tsuboi T, Iida H, Yamagata H, Hishimoto A, Horai T, Usami M, Makinodan M, Nagasawa T, Komatsu H, Kido M, Muraoka H, Atake K, Takeshima M, Kubota C, Inagaki T, Tamai S, Kishimoto T, Furihata R, Matsumoto J, Miura K, Inada K, Watanabe K, Kasai K, Hashimoto R. Asian J Psychiatr. 2022 Mar;69:103007. doi: 10.1016/j.ajp.2022.103007. Epub 2022 Jan 13. PMID: 35051727

Structural brain abnormalities in adolescent patients with anorexia nervosa at both the acute and weight-recovered phase. Asami T, Takaishi M, Nakamura R, Yoshimi A, Konishi J, Aoyama K, Fujita J, Miyazaki H, Aoki Y, Asanuma K, Hattori S, Suda A, Whitford TJ, Hirayasu Y, Hishimoto A. Brain Imaging Behav. 2022 Jun;16(3):1372-1380. doi: 10.1007/s11682-021-00622-5. Epub 2022 Jan 13. PMID: 35025002

Searching for biomarkers in schizophrenia and psychosis: Case-control study using capillary electrophoresis and liquid chromatography time-of-flight mass spectrometry and systematic review for biofluid metabolites. Kim S, Okazaki S, Otsuka I, Shinko Y, Horai T, Shimmyo N, Hirata T, Yamaki N, Tanifuji T, Boku S, Sora I, Hishimoto A. Neuropsychopharmacol Rep. 2022 Mar;42(1):42-51. doi: 10.1002/npr2.12223. Epub 2021 Dec 8. PMID: 34889082